NEURAXIS, INC. Cash Equivalents, at Carrying Value
NEURAXIS, INC. (NRXS) had Cash Equivalents, at Carrying Value of $0 as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-19
- 2025-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2024-12-31: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-19 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |